1. Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study. (5th May 2022) Authors: Poullenot, F; Amiot, A; Nachury, M; Viennot, S; Altwegg, R; Bouhnik, Y; Abitbol, V; Nancey, S; Vuitton, L; Peyrin-Biroulet, L; Biron, A; Fumery, M; Picon, L; Vidon, M; Reenaers, C; Serrero, M; Savoye, G; Beaugerie, L; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 10(2022) Page Start: 1523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn's disease in a prospective European population-based inception cohort: the Epi-IBD cohort. (16th January 2018) Authors: Burisch, J; Andersen, V; Čuković-Čavka, S; Lakatos, P L; D'Inca, R; Magro, F; Arebi, N; Kievit, L; Kaimakliotis, I; Valpiani, D; Katsanos, K H; Vegh, Z; Dahlerup, J F; Fumery, M; Pedersen, N; Halfvarson, J; Belousova, E; Nielsen, K R; Turcan, S; Ellul, P Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S042 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP029 Treatment and long-term outcomes of paediatric patients with penetrating Crohn's disease. (16th January 2018) Authors: Kollen, L; Leroyer, A; Breton, A; Fumery, M; Savoye, G; Lemale, J; Morin, D; Pariente, B; Mas, E; Turck, D; Al Khouri, M; Blanc, P; Gower, C; Pineton de Chambrun, G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP06 Non-invasive identification of adherent-invasive E. coli in patients with Crohn's disease. (15th January 2020) Authors: Buisson, A; Vazeille, E; Hébuterne, X; Fumery, M; Pariente, B; Nancey, S; Seksik, P; Peyrin-Biroulet, L; Allez, M; Ballet, N; Billard, E; Rodriguez, S; Pereira, B; Barnich, N Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP33 Role of adherent and invasive E. coli in Crohn's Disease: Lessons from the postoperative recurrence model. (21st January 2022) Authors: Buisson, A; Sokol, H; Hammoudi, N; Nancey, S; Treton, X; Nachury, M; Fumery, M; Hébuterne, X; Rodrigues, M; Hugot, J P; Boschetti, G; Stefanescu, C; Wils, P; Seksik, P; Le Bourhis, L; Bezault, M; Sauvanet, P; Pereira, B; Allez, M; Barnich, N Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP34 Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn's Disease for modified Rutgeerts' score i2a and i2b categories: Individual patient data meta-analysis. (21st January 2022) Authors: Riviere, P; Pekow, J; Hammoudi, N; Wils, P; De Cruz, P; Wang, C; Mañosa, M; Ollech, J; Allez, M; Nachury, M; Kamm, M; Maya, A; Ferrante, M; Buisson, A; Singh, S; Laharie, D; Momar, D; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP45 Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE. (30th January 2023) Authors: Matsuoka, K; Löwenberg, M; Fumery, M; Takatori, Y; Fujitani, Y; Oortwijn, A; Faes, M; Jamoul, C; Hibi, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP74 Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study. (25th January 2019) Authors: Biron, C; Seksik, P; Nachury, M; Bouhnik, Y; Amiot, A; Viennot, S; Serrero, M; Fumery, M; Allez, M; Siproudhis, L; Buisson, A; Pineton de Chambrun, G; Abitbol, V; Nancey, S; Caillo, L; Plastaras, L; Armengol-Debeir, L; Chanteloup, E; Simon, M; Dib, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent. (21st January 2022) Authors: Buisson, A; Nachury, M; Fumery, M; Guilmoteau, T; Leclerc, E; Altwegg, R; Serrero, M; Mathieu, N; Treton, X; Vuitton, L; Pereira, B; Amiot, A; Bouguen, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DOP78 Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study. (25th January 2019) Authors: Biron, C; Seksik, P; Nachury, M; Nancey, S; Bouhnik, Y; Serrero, M; Armengol-Debeir, L; Buisson, A; Tran Minh, M-L; Zallot, C; Fumery, M; Bouguen, G; Abitbol, V; Viennot, S; Chanteloup, E; Rajca, S; Dib, N; Peyrin-Biroulet, L; Vuitton, L Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗